Sandoz

This study tested a biosimilar (a nearly identical copy) of the cancer drug nivolumab (Opdivo) in people with advanced melanoma that cannot be removed by surgery or has spread. The goal was to see if the biosimilar works as well and is as safe as the original drug when used with …